The success of transcatheter aortic valve implantation (TAVI) is centred around the collaboration between cardiac surgeons and interventional cardiologists. A report from the German Quality Assurance ...

Women receiving transcatheter aortic valve implantation face higher periprocedural complication risks but better long-term survival than men.

A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...

June is not as busy as May when it comes to medical meetings, although multiple stories from the recent New York Valves 2026 conference feature in the most-read articles from the past month. TAVI news ...

Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular ...

The introduction of transcatheter aortic valve implantation (TAVI) has substantially changed the treatment of aortic stenosis in high-risk surgical patients in the past 10 years Problems with the ...

Clinical suitability is the primary requirement for selection of a patient for TAVI. Although TAVI compares favorably to conservative treatment in patients at high risk of or inoperable by ...

Abbott is now entering a corner of the medical device space that has been dominated by Edwards Lifesciences and Medtronic. On Tuesday, the company earned FDA approval for its latest transcatheter ...

CHICAGO — For older patients at high risk for a heart failure event who are scheduled for transcatheter aortic valve implantation (TAVI), dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) ...